# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001641172-25-014722
Filing Date
2025-06-11
Accepted
2025-06-11 16:31:38
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | formdefa14a.htm | DEFA14A | 13773
2 | GRAPHIC | proxy_001.jpg | GRAPHIC | 437971
3 | GRAPHIC | proxy_002.jpg | GRAPHIC | 407032
| Complete submission text file | 0001641172-25-014722.txt |  | 1179109

Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40023 | Film No.: 251040479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)